NCT03780452

Brief Summary

The purpose of this study is to determine the clinical efficacy of a novel dynamic compression intramedullary nail for tibiotalocalcaneal (TTC) arthrodesis

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 19, 2018

Completed
1.9 years until next milestone

Study Start

First participant enrolled

November 15, 2020

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2024

Completed
11 months until next milestone

Results Posted

Study results publicly available

May 22, 2025

Completed
Last Updated

May 31, 2025

Status Verified

May 1, 2025

Enrollment Period

3.7 years

First QC Date

December 17, 2018

Results QC Date

April 16, 2025

Last Update Submit

May 21, 2025

Conditions

Keywords

intramedullary nailarthrodesissubtalartibiotalar

Outcome Measures

Primary Outcomes (4)

  • Pain Assessment

    Visual Analog Scale (VAS). Patients will disclose their pain level using the Visual Analog Scale, which measures pain on a scale of 0 - 100, with 0 indicating no pain and 100 indicating severe pain.

    0 - 12 months postoperatively

  • Functional Assessment

    Foot and Ankle Ability Measure (FAAM). The FAAM is made up of a 21-item activity of daily living (ADL) and and 8-item sports subscale, which are combined to form a single total score. The ADL subscale ranges from 0 to 84 and the sports from 0 to 32. The total score is a calculated by adding the two subscores together and then reporting as a percentage of the total possible score (116). The percent score range is from 0% to 100%. For interpretation of the results a score closure to 100% is considered greater function.

    0 - 12 months postoperatively

  • Change in Functional Assessment

    The Short Form 36 (SF-36) is a total of 36 questions covering 8 domains of health: (1) limitations in physical activities, (2) limitations in social activities, (3) limitations in usual role activities due to physical health problems, (4) bodily pain, (5) general mental health, (6) Limitations in usual role activities due to emotional problems, (7) Vitality, and (8) General health perceptions. The domain scores are added together for a total score. The total is a reported as a percentage from 0% to 100% with 50 serving as the normative value. Higher scores represent a greater level of functioning.

    0 - 12 months postoperatively

  • Fusion, as Measured by Radiograph and CT Scan

    radiographs taken Pre-operatively, 2 weeks, 4 weeks, 6 weeks, 3 Months, 6 Months, 12 Months and 24 Months. A CT scan will be done at 6 months.

    0 - 12 months postoperative

Study Arms (1)

Tibiotalocalcaneal arthrodesis with DynaNail

Tibiotalocalcaneal arthrodesis with a novel dynamic compression intramedullary nail

Device: novel dynamic compression intramedullary nail

Interventions

Tibiotalocalcaneal (TTC) arthrodesis with a novel dynamic compression intramedullary nail. The assignment of the device is at the discretion of the standard of care provider, not the study investigator.

Tibiotalocalcaneal arthrodesis with DynaNail

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be identified in the clinic by an attending orthopaedic foot and ankle surgeon, his clinical fellow, or his physician assistant based on clinical exam and radiographic findings. Inclusion criteria include anyone over age 18 who has ankle and subtalar arthritis and has failed nonoperative management. Typically, these patients have multiple medical comorbidities and therefore the only exclusion criteria will be patients who are not healthy enough to undergo surgery. Patients of all racial, religious, and cultural backgrounds will be included in this study.

You may qualify if:

  • Over the age of 18
  • Ankle and Subtalar arthritis
  • Failed non-operative management

You may not qualify if:

  • Patients who do not meet the minimum age of 18 years.
  • patients who are not eligible to undergo surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama

Birmingham, Alabama, 35205, United States

Location

MeSH Terms

Conditions

Ankylosis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Results Point of Contact

Title
Dr. Ashish Shah
Organization
UAB Department of Orthopaedic Surgery

Study Officials

  • ashish shah, md

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary Investigator

Study Record Dates

First Submitted

December 17, 2018

First Posted

December 19, 2018

Study Start

November 15, 2020

Primary Completion

July 10, 2024

Study Completion

July 10, 2024

Last Updated

May 31, 2025

Results First Posted

May 22, 2025

Record last verified: 2025-05

Locations